Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients

This publication has 15 references indexed in Scilit:

• Immunomodulatory Effects of Etanercept in an Experimental Model of Spinal Cord Injury
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Differential Expression of Phosphorylated NF-κB/RelA in Normal and Psoriatic Epidermis and Downregulation of NF-κB in Response to Treatment with Etanercept
  Journal of Investigative Dermatology, 2005
• Psoriasis pathophysiology: current concepts of pathogenesis
  Annals of the Rheumatic Diseases, 2005
• Evidence that anti–tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: Extended report
  Arthritis & Rheumatism, 2005
• Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and ‘Type 1’ inflammatory gene expression
  Trends in Immunology, 2004
• Interactions of fluorochrome‐labeled caspase inhibitors with apoptotic cells: A caution in data interpretation
  Cytometry Part A, 2003
• Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris
  Journal of the American Academy of Dermatology, 2003
• Role of NF-κB Activity in Apoptotic Response of Keratinocytes Mediated by Interferon-γ, Tumor Necrosis Factor-α, and Tumor-Necrosis-Factor-Related Apoptosis-Inducing Ligand
  Journal of Investigative Dermatology, 2001
• PSORIASIS
  Dermatologic Clinics, 2001
• Histamine in Human Epidermal Cells is Induced by Ultraviolet Light Injury
  Journal of Investigative Dermatology, 1996